The tumor microenvironment can trigger the release of key proinflammatory mediators including interleukin-6 (IL-6), IL-1, and IL-1β, which stimulate hepatocyte CRP production, leading to a marked increase in plasma CRP (24–26). Here, CRP is linked to neoplasm.